CDH1 and neoplasm: To examine the association between activated pSrc levels and reduced E-cadherin expression, human PDAC tumor samples were analyzed by immunohistochemistry for pSrc and stratified into pSrclow (N=5) and pSrchigh (N=5) groups based on tissue levels (Supplementary Figure 1B).